Literature DB >> 16952540

Ground-glass, polyglucosan-like hepatocellular inclusions: A "new" diagnostic entity.

Jay H Lefkowitch1, Steven J Lobritto, Robert S Brown, Jean C Emond, Michael L Schilsky, Lori A Rosenthal, Diane M George, Mitchell S Cairo.   

Abstract

BACKGROUND & AIMS: Ground-glass (GG) inclusions within hepatocytes are an important histopathologic marker of chronic hepatitis B virus (HBV) infection but may also be seen in Lafora's disease (myoclonus epilepsy), cyanamide alcohol aversion therapy, and type IV glycogenosis. We have noted a recent increased incidence of liver biopsy and postmortem specimens with GG inclusions associated with none of these etiologic factors. This study was undertaken to further delineate the clinical and liver pathologic features in such cases and their possible pathogenesis.
METHODS: Ten cases with GG inclusions (8 biopsy, 2 postmortem) were examined by light and electron microscopy, and the patients' clinical records were reviewed.
RESULTS: Light microscopy demonstrated pale pink, oval to crescentic intracytoplasmic inclusions with a predilection for periportal hepatocytes but sometimes present throughout the lobules. The inclusions were intensely positive on periodic acid-Schiff stain and digested with diastase. Transmission electron microscopy of two cases showed non-membrane-bound cytoplasmic collections of granules with mild-to-moderate electron density, consistent with abnormal glycogen granules. The patients included 7 transplant recipients (liver, hematopoietic stem cell), 3 with type 2 diabetes and a child on chronic parenteral nutrition for short bowel syndrome. Medications included immunosuppressive agents, antibiotics, and insulin.
CONCLUSIONS: GG hepatocellular inclusions may be seen in individuals without HBV infection or other recognized etiologies, appear to be composed of abnormal glycogen and closely resemble polyglucosan bodies described in humans, animals, and experimental models. The possible pathogenetic roles of disturbed glycogen metabolism and polypharmacotherapy are stressed.

Entities:  

Mesh:

Year:  2006        PMID: 16952540     DOI: 10.1053/j.gastro.2006.07.006

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  6 in total

1.  NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report.

Authors:  Howard M Shulman; Diana M Cardona; Joel K Greenson; Sangeeta Hingorani; Thomas Horn; Elisabeth Huber; Andreas Kreft; Thomas Longerich; Thomas Morton; David Myerson; Victor G Prieto; Avi Rosenberg; Nathaniel Treister; Kay Washington; Mirjana Ziemer; Steven Z Pavletic; Stephanie J Lee; Mary E D Flowers; Kirk R Schultz; Madan Jagasia; Paul J Martin; Georgia B Vogelsang; David E Kleiner
Journal:  Biol Blood Marrow Transplant       Date:  2015-01-29       Impact factor: 5.742

2.  Trichrome-positive intrahepatic cytoplasmic globules are potential histopathological clue for COVID-19-induced hepatitis: a case report.

Authors:  Dina Sweed; Mohamed Ramadan El Shanshory; Eman Mohammed Elaskary; Hassnaa Atef Hassan; Enas Sweed; Eman Sweed; Shimaa Abdelsattar; Ahmed Abdelgawad; Asmaa Mosbeh; Heba Abdallah; Shereen El-Mashad; Nermine Ehsan
Journal:  Egypt Liver J       Date:  2021-08-23

Review 3.  Recent Advances in the Histopathology of Drug-Induced Liver Injury.

Authors:  David E Kleiner
Journal:  Surg Pathol Clin       Date:  2018-06

4.  Hepatic involvement in Wegener's granulomatosis: a case report.

Authors:  Constantin Goritsas; Nicolas P Paissios; Rodoula Trigidou; Joanna Delladetsima
Journal:  J Med Case Rep       Date:  2010-01-14

5.  Hepatocellular type II fibrinogen inclusions in a patient with severe COVID-19 and hepatitis.

Authors:  Montserrat Fraga; Darius Moradpour; Florent Artru; Elodie Romailler; Jonathan Tschopp; Antoine Schneider; Haithem Chtioui; Marguerite Neerman-Arbez; Alessandro Casini; Lorenzo Alberio; Christine Sempoux
Journal:  J Hepatol       Date:  2020-06-22       Impact factor: 25.083

6.  Pathomorphogenesis of Glycogen-Ground Glass Hepatocytic Inclusions (Polyglucosan Bodies) in Children after Liver Transplantation.

Authors:  Francesco Callea; Paola Francalanci; Chiara Grimaldi; Francesca Diomedi Camassei; Rita Devito; Fabio Facchetti; Rita Alaggio; Emanuele Bellacchio
Journal:  Int J Mol Sci       Date:  2022-09-02       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.